Global Filters




Tiers


Species


Attribution

Filter by Tier
Filter by Species
Filter by Attributions
like "mouse, Ap3m2, alcohol"

Returning 822 results: Page 1 of 33


Tier Species Size Attr. GeneSet
Tier II 58 GS129189: survival time modifier of Sod2 (Svtms Published QTL Chr 13)
Tier I 98 GS268160: GWAS Catalog Data for response to bronchodilator, chronic obstructive pulmonary disease, FEV/FEC ratio in 5,439 European ancestry current and former smoker cases, 821 African American current and former smoker cases
Tier III 17420 GS400133: Transcriptome of the human dorsolateral prefrontal cortex of people with a history of cocaine use vs control (RNA-seq)
Tier IV 1995 GS407294: Up regulated gene expression of iPSCs, induced to form neuronal progenitor cells (NPCs), with a CRISPR edited pathogenic variant, EHMT1_SNV, as a model for Kleefstra syndrome
Tier IV 1995 GS407296: Up regulated gene expression of neuronal progenitor cells (NPCs) compared to iPSCs (both Wild Type), in a CRISPR edited pathogenic variant EHMT1_SNV study, as a model for Kleefstra syndrome
Tier IV 1995 GS407298: Up regulated gene expression of neuronal progenitor cells (NPC) and iPSC, with a CRISPR edited pathogenic variant, EHMT1_SNV, as a model for Kleefstra syndrome
Tier III 26035 GS407934: Differentially expressed genes of post mortem human central Amygdala samples in patients affected by opioid use disorder (OUD) vs. unaffected control samples_qvalue
Tier IV 10391 GS408184: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, log2FC
Tier IV 11875 GS408185: Differential gene expression comparison between Carnegie Stages (CS) 13 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 10612 GS408188: Differential gene expression comparison between Carnegie Stages (CS) 14 and 22 during human embryo craniofacial development, Adj-P value
Tier IV 13854 GS408215: Transcriptional differences in dorsolateral prefrontal cortex (DLPFC) in human opioid use disorder subjects_coefficient
Tier IV 13854 GS408217: Transcriptional differences in nucleus accumbens (NAc) in human opioid use disorder subjects_coefficient
Tier IV 8709 GS391: RIKEN Cerebellum C57BL/6J Development Series
Tier III 142 GS855: Sey_Pax6_Int_No_Change_Lin_Inc
Tier III 14 GS1263: Preferentially expressed higher genes in Inbred Long Sleep
Tier II 163 GS26229: Cerebellum Gene expression correlates of Thermal Nociception Hot Plate Avg of 2Trials in Females BXD
Tier III 49 GS26276: Neocortex Gene expression correlates of Mechanical Sensitivity-Von Frey Threshold [Pain] in Males BXD
Tier II 344 GS26280: Hippocampus Gene expression correlates of Mechanical Sensitivity-Von Frey Threshold in Females & Males BXD
Tier II 129 GS34039: Hippocampus Gene expression correlates of Open Field locomotion (cm) 30-45 min post cocaine in Females BXD
Tier III 129 GS34044: Hippocampus Gene expression correlates of Open Field locomotion (cm) 30-45 min post cocaine [Cocaine] in Females BXD
Tier II 431 GS34108: Hippocampus Gene expression correlates of Open Field locomotion (activity beam breaks) 30-45 min post 2nd cocaine in Males BXD
Tier II 209 GS34118: Hippocampus Gene expression correlates of Open Field locomotion (activity beam breaks) 45-60 min post 2nd cocaine in Males BXD
Tier II 427 GS34138: Hippocampus Gene expression correlates of Open Field locomotion (cm) 30-45 min post 2nd cocaine in Males BXD
Tier II 209 GS34173: Hippocampus Gene expression correlates of Open Field rears 45-60 min post 2nd cocaine in Males BXD
Tier II 4 GS34179: Neocortex Gene expression correlates of Morphine Response Severity of abdominal constriction in Females & Males BXD